# Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment

> **NCT02917057** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 6024 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** exenatide once weekly
- **DRUG:** basal insulin

## Key facts

- **NCT ID:** NCT02917057
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-01
- **Primary completion:** 2015-08-01
- **Final completion:** 2015-08-01
- **Target enrollment:** 6024 (ACTUAL)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02917057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02917057, "Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02917057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*